UniProt ID | TRA2B_HUMAN | |
---|---|---|
UniProt AC | P62995 | |
Protein Name | Transformer-2 protein homolog beta | |
Gene Name | TRA2B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 288 | |
Subcellular Localization | Nucleus . | |
Protein Description | Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing. Can either activate or suppress exon inclusion. Acts additively with RBMX to promote exon 7 inclusion of the survival motor neuron SMN2. Activates the splicing of MAPT/Tau exon 10. Alters pre-mRNA splicing patterns by antagonizing the effects of splicing regulators, like RBMX. Binds to the AG-rich SE2 domain in the SMN exon 7 RNA. Binds to pre-mRNA.. | |
Protein Sequence | MSDSGEQNYGERESRSASRSGSAHGSGKSARHTPARSRSKEDSRRSRSKSRSRSESRSRSRRSSRRHYTRSRSRSRSHRRSRSRSYSRDYRRRHSHSHSPMSTRRRHVGNRANPDPNCCLGVFGLSLYTTERDLREVFSKYGPIADVSIVYDQQSRRSRGFAFVYFENVDDAKEAKERANGMELDGRRIRVDFSITKRPHTPTPGIYMGRPTYGSSRRRDYYDRGYDRGYDDRDYYSRSYRGGGGGGGGWRAAQDRDQIYRRRSPSPYYSRGGYRSRSRSRSYSPRRY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSDSGEQNY ------CCCCCCCCC | 40.25 | 21406692 | |
2 | Phosphorylation | ------MSDSGEQNY ------CCCCCCCCC | 40.25 | 29255136 | |
4 | Phosphorylation | ----MSDSGEQNYGE ----CCCCCCCCCCC | 36.60 | 23401153 | |
9 | Phosphorylation | SDSGEQNYGERESRS CCCCCCCCCCCCCCC | 21.76 | 17081983 | |
14 | Phosphorylation | QNYGERESRSASRSG CCCCCCCCCCCCCCC | 37.44 | 29255136 | |
16 | Phosphorylation | YGERESRSASRSGSA CCCCCCCCCCCCCCC | 39.62 | 25159151 | |
18 | Phosphorylation | ERESRSASRSGSAHG CCCCCCCCCCCCCCC | 28.38 | 25159151 | |
20 | Phosphorylation | ESRSASRSGSAHGSG CCCCCCCCCCCCCCC | 34.31 | 30576142 | |
22 | Phosphorylation | RSASRSGSAHGSGKS CCCCCCCCCCCCCCC | 20.52 | 25849741 | |
26 | Phosphorylation | RSGSAHGSGKSARHT CCCCCCCCCCCCCCC | 32.93 | 26055452 | |
29 | Phosphorylation | SAHGSGKSARHTPAR CCCCCCCCCCCCCCC | 33.78 | 26055452 | |
33 | Phosphorylation | SGKSARHTPARSRSK CCCCCCCCCCCCCCH | 17.06 | 26055452 | |
37 | Phosphorylation | ARHTPARSRSKEDSR CCCCCCCCCCHHHHH | 42.91 | 26055452 | |
39 | Phosphorylation | HTPARSRSKEDSRRS CCCCCCCCHHHHHHH | 41.46 | 22167270 | |
40 | Ubiquitination | TPARSRSKEDSRRSR CCCCCCCHHHHHHHH | 65.51 | 23000965 | |
40 (in isoform 3) | Ubiquitination | - | 65.51 | 21890473 | |
43 | Phosphorylation | RSRSKEDSRRSRSKS CCCCHHHHHHHHHHH | 30.59 | 22167270 | |
46 | Phosphorylation | SKEDSRRSRSKSRSR CHHHHHHHHHHHHHH | 39.53 | 24719451 | |
63 | Phosphorylation | SRSRSRRSSRRHYTR HHHHHHHHHHHHHHH | 27.38 | 17081983 | |
68 | Phosphorylation | RRSSRRHYTRSRSRS HHHHHHHHHHHHHHC | 11.31 | 23663014 | |
69 | Phosphorylation | RSSRRHYTRSRSRSR HHHHHHHHHHHHHCH | 18.95 | 20363803 | |
71 | Phosphorylation | SRRHYTRSRSRSRSH HHHHHHHHHHHCHHH | 27.14 | 20363803 | |
73 | Ubiquitination | RHYTRSRSRSRSHRR HHHHHHHHHCHHHHH | 35.54 | 33845483 | |
73 (in isoform 3) | Ubiquitination | - | 35.54 | 21890473 | |
81 | Phosphorylation | RSRSHRRSRSRSYSR HCHHHHHHHCHHCCH | 34.27 | 22798277 | |
83 | Phosphorylation | RSHRRSRSRSYSRDY HHHHHHHCHHCCHHH | 27.16 | 22167270 | |
85 | Phosphorylation | HRRSRSRSYSRDYRR HHHHHCHHCCHHHHH | 28.80 | 22167270 | |
86 | Phosphorylation | RRSRSRSYSRDYRRR HHHHCHHCCHHHHHH | 13.45 | 22167270 | |
87 | Phosphorylation | RSRSRSYSRDYRRRH HHHCHHCCHHHHHHH | 21.66 | 22167270 | |
90 | Phosphorylation | SRSYSRDYRRRHSHS CHHCCHHHHHHHCCC | 12.62 | 22167270 | |
95 | Phosphorylation | RDYRRRHSHSHSPMS HHHHHHHCCCCCCCC | 25.52 | 29255136 | |
97 | Phosphorylation | YRRRHSHSHSPMSTR HHHHHCCCCCCCCHH | 28.77 | 22167270 | |
97 | Ubiquitination | YRRRHSHSHSPMSTR HHHHHCCCCCCCCHH | 28.77 | 23000965 | |
97 (in isoform 3) | Ubiquitination | - | 28.77 | 21890473 | |
99 | Phosphorylation | RRHSHSHSPMSTRRR HHHCCCCCCCCHHCC | 25.88 | 29255136 | |
101 | Phosphorylation | HSHSHSPMSTRRRHV HCCCCCCCCHHCCCC | 7.77 | 32645325 | |
102 | Phosphorylation | SHSHSPMSTRRRHVG CCCCCCCCHHCCCCC | 23.34 | 29255136 | |
103 | Phosphorylation | HSHSPMSTRRRHVGN CCCCCCCHHCCCCCC | 23.18 | 29255136 | |
119 | Glutathionylation | ANPDPNCCLGVFGLS CCCCCCCEEHHHCEE | 4.75 | 22555962 | |
140 | Acetylation | DLREVFSKYGPIADV HHHHHHHHHCCCCEE | 42.64 | 26051181 | |
140 | Ubiquitination | DLREVFSKYGPIADV HHHHHHHHHCCCCEE | 42.64 | 23000965 | |
140 (in isoform 1) | Ubiquitination | - | 42.64 | 21890473 | |
141 | Methylation | LREVFSKYGPIADVS HHHHHHHHCCCCEEE | 27.25 | 15782174 | |
141 | Phosphorylation | LREVFSKYGPIADVS HHHHHHHHCCCCEEE | 27.25 | 28152594 | |
148 | Phosphorylation | YGPIADVSIVYDQQS HCCCCEEEEEEECCC | 13.59 | 28555341 | |
155 | Phosphorylation | SIVYDQQSRRSRGFA EEEEECCCCCCCCEE | 24.83 | 21712546 | |
164 | Phosphorylation | RSRGFAFVYFENVDD CCCCEEEEEEECCCC | 4.86 | 32142685 | |
166 | Phosphorylation | RGFAFVYFENVDDAK CCEEEEEEECCCCHH | 4.65 | 32142685 | |
173 | 2-Hydroxyisobutyrylation | FENVDDAKEAKERAN EECCCCHHHHHHHHC | 66.26 | - | |
173 | Acetylation | FENVDDAKEAKERAN EECCCCHHHHHHHHC | 66.26 | 26051181 | |
173 | Ubiquitination | FENVDDAKEAKERAN EECCCCHHHHHHHHC | 66.26 | 33845483 | |
173 (in isoform 1) | Ubiquitination | - | 66.26 | 21890473 | |
176 | Ubiquitination | VDDAKEAKERANGME CCCHHHHHHHHCCCE | 49.15 | - | |
187 | Methylation | NGMELDGRRIRVDFS CCCEECCEEEEEEEE | 30.44 | - | |
194 | Phosphorylation | RRIRVDFSITKRPHT EEEEEEEEEECCCCC | 25.53 | 26074081 | |
196 | Phosphorylation | IRVDFSITKRPHTPT EEEEEEEECCCCCCC | 21.58 | 26074081 | |
197 | 2-Hydroxyisobutyrylation | RVDFSITKRPHTPTP EEEEEEECCCCCCCC | 63.36 | - | |
197 | Acetylation | RVDFSITKRPHTPTP EEEEEEECCCCCCCC | 63.36 | 25953088 | |
197 | Sumoylation | RVDFSITKRPHTPTP EEEEEEECCCCCCCC | 63.36 | 28112733 | |
197 | Ubiquitination | RVDFSITKRPHTPTP EEEEEEECCCCCCCC | 63.36 | 23000965 | |
197 (in isoform 1) | Ubiquitination | - | 63.36 | 21890473 | |
201 | Phosphorylation | SITKRPHTPTPGIYM EEECCCCCCCCCEEC | 31.38 | 29255136 | |
203 | Phosphorylation | TKRPHTPTPGIYMGR ECCCCCCCCCEECCC | 34.99 | 22167270 | |
207 | Phosphorylation | HTPTPGIYMGRPTYG CCCCCCEECCCCCCC | 10.22 | 23927012 | |
210 | Methylation | TPGIYMGRPTYGSSR CCCEECCCCCCCCCC | 12.12 | 54559211 | |
212 | Phosphorylation | GIYMGRPTYGSSRRR CEECCCCCCCCCCCC | 38.87 | 25159151 | |
213 | Phosphorylation | IYMGRPTYGSSRRRD EECCCCCCCCCCCCC | 20.07 | 23927012 | |
215 | Phosphorylation | MGRPTYGSSRRRDYY CCCCCCCCCCCCCCH | 15.40 | 23927012 | |
216 | Phosphorylation | GRPTYGSSRRRDYYD CCCCCCCCCCCCCHH | 25.99 | 23927012 | |
217 | Methylation | RPTYGSSRRRDYYDR CCCCCCCCCCCCHHC | 39.07 | - | |
221 | Phosphorylation | GSSRRRDYYDRGYDR CCCCCCCCHHCCCCC | 12.88 | 25367160 | |
222 | Phosphorylation | SSRRRDYYDRGYDRG CCCCCCCHHCCCCCC | 11.94 | 25367160 | |
224 | Methylation | RRRDYYDRGYDRGYD CCCCCHHCCCCCCCC | 29.47 | 81453753 | |
226 | Phosphorylation | RDYYDRGYDRGYDDR CCCHHCCCCCCCCCC | 11.89 | 28152594 | |
228 | Methylation | YYDRGYDRGYDDRDY CHHCCCCCCCCCCCC | 36.77 | 80701933 | |
230 | Phosphorylation | DRGYDRGYDDRDYYS HCCCCCCCCCCCCCC | 18.63 | 28796482 | |
233 | Methylation | YDRGYDDRDYYSRSY CCCCCCCCCCCCCCC | 30.82 | 81121037 | |
235 | Phosphorylation | RGYDDRDYYSRSYRG CCCCCCCCCCCCCCC | 12.30 | 27273156 | |
236 | Phosphorylation | GYDDRDYYSRSYRGG CCCCCCCCCCCCCCC | 11.25 | 28796482 | |
237 | Phosphorylation | YDDRDYYSRSYRGGG CCCCCCCCCCCCCCC | 14.44 | 28796482 | |
238 | Methylation | DDRDYYSRSYRGGGG CCCCCCCCCCCCCCC | 22.91 | 80701925 | |
240 | Phosphorylation | RDYYSRSYRGGGGGG CCCCCCCCCCCCCCC | 16.50 | - | |
241 | Asymmetric dimethylarginine | DYYSRSYRGGGGGGG CCCCCCCCCCCCCCC | 38.23 | - | |
241 | Methylation | DYYSRSYRGGGGGGG CCCCCCCCCCCCCCC | 38.23 | 24129315 | |
251 | Methylation | GGGGGGWRAAQDRDQ CCCCCCCHHCCCHHH | 24.26 | 80701941 | |
256 | Methylation | GWRAAQDRDQIYRRR CCHHCCCHHHHHHCC | 26.17 | 115918885 | |
260 | Phosphorylation | AQDRDQIYRRRSPSP CCCHHHHHHCCCCCC | 7.76 | 21609022 | |
264 | Phosphorylation | DQIYRRRSPSPYYSR HHHHHCCCCCCCCCC | 28.11 | 26846344 | |
266 | Phosphorylation | IYRRRSPSPYYSRGG HHHCCCCCCCCCCCC | 27.12 | 19664994 | |
268 | Phosphorylation | RRRSPSPYYSRGGYR HCCCCCCCCCCCCCC | 20.57 | 20201521 | |
269 | Phosphorylation | RRSPSPYYSRGGYRS CCCCCCCCCCCCCCC | 8.69 | 23927012 | |
270 | Phosphorylation | RSPSPYYSRGGYRSR CCCCCCCCCCCCCCC | 20.71 | 26846344 | |
271 | Methylation | SPSPYYSRGGYRSRS CCCCCCCCCCCCCCC | 26.83 | 115367923 | |
274 | Phosphorylation | PYYSRGGYRSRSRSR CCCCCCCCCCCCCCC | 14.29 | 29116813 | |
276 | Phosphorylation | YSRGGYRSRSRSRSY CCCCCCCCCCCCCCC | 26.56 | 29116813 | |
278 | Phosphorylation | RGGYRSRSRSRSYSP CCCCCCCCCCCCCCC | 35.54 | 26846344 | |
280 | Phosphorylation | GYRSRSRSRSYSPRR CCCCCCCCCCCCCCC | 27.16 | 26846344 | |
282 | Phosphorylation | RSRSRSRSYSPRRY- CCCCCCCCCCCCCC- | 31.07 | 26846344 | |
283 | Phosphorylation | SRSRSRSYSPRRY-- CCCCCCCCCCCCC-- | 22.91 | 26846344 | |
284 | Phosphorylation | RSRSRSYSPRRY--- CCCCCCCCCCCC--- | 17.12 | 28355574 | |
288 | Phosphorylation | RSYSPRRY------- CCCCCCCC------- | 24.96 | 21406692 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRA2B_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRA2B_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RBMX_HUMAN | RBMX | physical | 12165565 | |
SRSF9_HUMAN | SRSF9 | physical | 11875052 | |
SAFB1_RAT | Safb | physical | 9671816 | |
SRSF3_HUMAN | SRSF3 | physical | 22365833 | |
SRSF6_HUMAN | SRSF6 | physical | 22365833 | |
ROA1_HUMAN | HNRNPA1 | physical | 22365833 | |
SRSF4_HUMAN | SRSF4 | physical | 22365833 | |
SRSF2_HUMAN | SRSF2 | physical | 22365833 | |
RBMX_HUMAN | RBMX | physical | 22365833 | |
SRS10_HUMAN | SRSF10 | physical | 22365833 | |
RNPS1_HUMAN | RNPS1 | physical | 14729963 | |
YTDC1_HUMAN | YTHDC1 | physical | 21988832 | |
DDX47_HUMAN | DDX47 | physical | 26344197 | |
EIF3I_HUMAN | EIF3I | physical | 26344197 | |
RNPS1_HUMAN | RNPS1 | physical | 26344197 | |
4F2_HUMAN | SLC3A2 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Methylation | |
Reference | PubMed |
"Identifying and quantifying in vivo methylation sites by heavy methylSILAC."; Ong S.E., Mittler G., Mann M.; Nat. Methods 1:119-126(2004). Cited for: METHYLATION [LARGE SCALE ANALYSIS] AT ARG-241, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND SER-14, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-85; SER-87;THR-201 AND THR-212, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-14; SER-264 ANDSER-266, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-201; TYR-207; SER-215AND SER-216, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-264 AND SER-266, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-29; THR-33;SER-37; SER-39; THR-69; SER-71; SER-95; SER-97; SER-99; SER-264;SER-266 AND SER-276, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-264 AND SER-266, ANDMASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-268 AND TYR-269, ANDMASS SPECTROMETRY. |